Invention Grant
US08859508B2 Application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression
有权
5-甲基-1,3-苯二酚或其衍生物在制备用于治疗或预防抑郁症的药物和功能性食品中的应用
- Patent Title: Application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression
- Patent Title (中): 5-甲基-1,3-苯二酚或其衍生物在制备用于治疗或预防抑郁症的药物和功能性食品中的应用
-
Application No.: US12669653Application Date: 2008-07-25
-
Publication No.: US08859508B2Publication Date: 2014-10-14
- Inventor: Jijun Chen , Lin Xu , Jun Zhou , Jun Lu , Rongrong Mao , Meng Tian , Qixin Zhou , Xuemei Zhang , Yong Shen , Zhiyong Jiang , Aixue Zuo
- Applicant: Jijun Chen , Lin Xu , Jun Zhou , Jun Lu , Rongrong Mao , Meng Tian , Qixin Zhou , Xuemei Zhang , Yong Shen , Zhiyong Jiang , Aixue Zuo
- Applicant Address: CN Kunming CN Kunming CN Kunming
- Assignee: Kunming Institute of Botany, Chinese Academy of Sciences,Kunming Institute of Zoology, Chinese Academy of Sciences,Kunming Jingbiao Biosciences R&D Co., Ltd.
- Current Assignee: Kunming Institute of Botany, Chinese Academy of Sciences,Kunming Institute of Zoology, Chinese Academy of Sciences,Kunming Jingbiao Biosciences R&D Co., Ltd.
- Current Assignee Address: CN Kunming CN Kunming CN Kunming
- Agency: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.
- Priority: CN200710066088 20070803
- International Application: PCT/CN2008/071752 WO 20080725
- International Announcement: WO2009/018747 WO 20090212
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/05 ; A23L1/30 ; A61K31/7032 ; C07H15/203
Abstract:
The present invention relates to the application of 5-methyl-1,3-benzenediol or its derivatives represented by Formula I; wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them in the preparation of medicines or functional foods. The present studies indicate that 5-methyl-1,3-benzenediol or its derivatives represented by Formula I, wherein the constituent variables are as defined herein or pharmaceutical compositions thereof containing them show more significant antidepressant effects than fluoxetine or imipramine.
Public/Granted literature
Information query
